Tizanidine vs Cyclobenzaprine for Back Pain
Direct Recommendation
Tizanidine is the preferred muscle relaxant for back pain over cyclobenzaprine, based on superior evidence quality, demonstrated efficacy in 8 trials for acute low back pain, and specific guideline recommendations from the American College of Physicians. 1, 2
Evidence Supporting Tizanidine
For acute low back pain:
- Tizanidine demonstrated efficacy in 8 clinical trials, while cyclobenzaprine has only 1 lower-quality trial for chronic low back pain that did not even report pain intensity or global efficacy 1
- The American College of Physicians specifically recommends tizanidine as the preferred muscle relaxant option due to its efficacy and safety profile 2, 3
- Tizanidine provides initial pain relief by day 2 and complete relief by day 4, compared to day 3 and day 7 respectively with NSAIDs alone 4
- When combined with acetaminophen or NSAIDs, tizanidine consistently provides greater short-term pain relief than monotherapy in high-quality trials 1, 2
For radicular symptoms (sciatica/leg pain):
- Tizanidine is the preferred muscle relaxant specifically for lumbar radiculopathy 2, 3
- Starting dose: 2-4 mg, titrated as needed 2, 3
Evidence on Cyclobenzaprine
Limited and lower-quality evidence:
- Only 1 lower-quality trial exists for cyclobenzaprine in chronic low back pain available in the United States, and it failed to report pain intensity or global efficacy 1
- A meta-analysis showed cyclobenzaprine is more effective than placebo (odds ratio 4.7), but the effect is modest (effect size 0.38-0.58) and greatest only in the first 4 days 5
- No significant difference was found between cyclobenzaprine and diazepam for global improvement in chronic low back pain 1
- Cyclobenzaprine has limited evidence specifically for radiculopathy 2
Practical Treatment Algorithm
Step 1: Initial therapy
- Start with NSAIDs as first-line treatment 3, 6
- If muscle spasm is prominent or NSAIDs provide inadequate relief, add tizanidine 3
Step 2: Tizanidine dosing
- Begin with 2 mg up to three times daily, particularly in older adults 2
- Titrate dose as needed based on response 2, 3
Step 3: Duration
- Limit treatment to 1-2 weeks (7-14 days) for acute back pain 2, 3
- Reassess after this time-limited course 2, 3
Step 4: For radicular symptoms
Safety Considerations and Monitoring
Common adverse effects (both agents):
- All skeletal muscle relaxants increase CNS adverse events (RR 2.04) compared to placebo 1
- Drowsiness is the most common side effect 1, 2
- Tizanidine: drowsiness occurred in 22% but was generally well-tolerated with adverse effects <6% 4, 7
- Cyclobenzaprine: drowsiness is common and adverse effects occur more frequently than with tizanidine 5
Specific monitoring for tizanidine:
Combination therapy benefits:
- Adding tizanidine to NSAIDs increases CNS adverse events (RR 2.44) but may reduce gastrointestinal adverse events (RR 0.54) 1, 2
Critical Pitfalls to Avoid
- Do not use long-term: Evidence supports only short-term use (1-2 weeks maximum) due to limited data on long-term benefits and risks 2, 3
- Do not use cyclobenzaprine for radiculopathy: Tizanidine has specific evidence for this indication while cyclobenzaprine does not 2
- Do not assume all muscle relaxants are equivalent: There is insufficient evidence that any specific muscle relaxant is superior to others in general, but tizanidine has the strongest evidence base for back pain specifically 1
- Assess response early: Evaluate pain relief within 2-4 days; if no improvement, reassess diagnosis and consider alternative therapies 2